<DOC>
	<DOC>NCT01491100</DOC>
	<brief_summary>Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.</brief_summary>
	<brief_title>Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Patients with Relapsing Remitting Multiple Sclerosis (RRMS), and treated with Betaferon, with the decision for treatment made at the discretion of the attending physician, documented with a prescription of Betaferon by the physician EDSS 0 6 Written informed consent Patients who do not meet the local indication criteria for Betaferon treatment. Contraindications listed in the local SmPCs have to be considered. Patients with a history of severe head trauma. Patients with alcohol and/or drug abuse. Patients with mental retardation. Patients with learning disability.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Relapsing Remitting Multiple Sclerosis</keyword>
</DOC>